dc.contributor.author | Zúñiga, Leyre | |
dc.contributor.author | Calvo Hernaez, Begoña | |
dc.date.accessioned | 2017-03-03T11:57:52Z | |
dc.date.available | 2017-03-03T11:57:52Z | |
dc.date.issued | 2010-05 | |
dc.identifier.citation | Hospital pharmacy Europe 50(May/June) : (2010) | es |
dc.identifier.issn | 1477-1896 | |
dc.identifier.uri | http://hdl.handle.net/10810/20854 | |
dc.description.abstract | Biotechnology represents a considerable opportunity, but also a challenge, given the complexities and risk associated with the
development and manufacture of biological medicines. | es |
dc.language.iso | eng | es |
dc.publisher | Cogora Limited | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.subject | biosimilars | es |
dc.title | Biosimilars – the way forward | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © Cogora Limited | es |
dc.relation.publisherversion | http://www.hospitalpharmacyeurope.com/issues/38945 | es |
dc.relation.publisherversion | http://www.hospitalpharmacyeurope.com/featured-articles/biosimilars-way-forward | es |
dc.departamentoes | Farmacia y ciencias de los alimentos | es_ES |
dc.departamentoeu | Farmazia eta elikagaien zientziak | es_ES |